Pricing Log in Create free account
Friday 6 November 2026 Export ASTH’s income statement to Excel — free account

Astrana Health, Inc.

ASTH Healthcare Medical Care Facilities

Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024.

Revenue
+7.07%
EPS
+2,500.0%
Free cash flow
−67.7%
Total debt
−94.3%

Quarter to September 2026, against a year earlier

33.74 5.27 −13.51%
Market cap
$1.9B
P/E
36.0×
Fwd P/E
25.9×
Dividend yield
—
F-score
4/9
Altman Z
2.39
Beneish M
−2.19
Dividend safety
50/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 22.91%

Capital & Financial Ratios $m

Size
Market Cap 1,940.00
Revenue ttm 3,911.76
Net income ttm 58.41
Free cash flow ttm 99.42
Net debt Q 59.83
Valuation
P/E 35.97 (above 35: high)
Forward P/E 25.90
Price / sales 0.49
Forward P/S Powerpack
Price / FCF 19.24
Price / book 2.20
Financial health
Current ratio Q 1.25
Debt / equity Q 0.07 (at or below 0.5: strong)
Interest coverage Q 2.65
Growth
Revenue growth Q +7.07% (above 0%: growing)
Operating income growth Q +107.60% (above 0%: growing)
EPS, this year +206.52% (at or above 15%: strong)
EPS, next year A +40.49% (at or above 15%: strong)
Revenue, next year A +25.15% (at or above 10%: strong)
EPS, past 5 yrs −14.55% (below 0%: weak)
EPS, next 5 yrs A +78.99% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.6×, against a ten-year median of 1.1×; over the ten years it ranged from 0.5× in 2026 to 5.3× in 2021.
P/E against its own 10 years 59.40%
10-year low 10-year high
P/S against its own 10 years 8.99%
10-year low 10-year high
P/B against its own 10 years 16.68%
10-year low 10-year high
EV/Sales against its own 10 years 10.48%
10-year low 10-year high
EV/FCF against its own 10 years 50.24%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 296 288 429 —
Receivables 148 325 403 —
Inventory — — — —
Other — — — —
462 638 863 980
2023 2024 2025 Q'26
Payables 60 106 196 273
ST’ Debt 20 9 48 60
Other 19 27 24 19
219 366 615 786

Compound Annual Growth %

10y 5y 3y
Sales 26.39% 35.87% 40.62%
Cash Flow 17.99% 19.94% 11.74%
Earnings 6.98% (9.81%) (20.75%)
Book Value 24.65% 19.11% 13.38%

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.31 Actual 0.40

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.47 0.01 Miss by 0.46
Q4 FY25 0.15 0.54 Beat by 0.39
Q1 FY25 0.29 0.74 Beat by 0.45
Q2 FY26 0.31 0.40 Beat by 0.09
Q3 FY26 0.44 — Reports 5 November 2026

EPS $

Mar Jun Sep Dec Year
’26 0.29 0.40 0.26 — —
’25 0.14 0.19 0.01 0.12 0.46
’24 0.31 0.40 0.33 (0.15) 0.90
’23 0.31 0.28 0.47 0.26 1.29
’22 0.31 0.25 0.56 (0.06) 1.08
’21 0.30 0.28 0.74 0.30 1.63
’20 0.11 0.19 0.45 0.27 1.01
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 965 973 1,024 — —
’25 620 655 956 951 3,182
’24 404 486 479 665 2,035
’23 337 348 348 353 1,387
’22 263 270 317 294 1,144
’21 176 176 227 195 774
’20 165 165 180 177 687
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 68 33 16 — —
’25 17 91 10 (3) 115
’24 6 23 34 (11) 52
’23 8 26 15 19 68
’22 24 9 (36) 85 82
’21 10 21 51 (12) 70
’20 (9) 22 36 (3) 46
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 64 29 12 — —
’25 14 89 7 (6) 104
’24 6 20 32 (13) 44
’23 (7) 23 11 12 40
’22 7 8 (39) 84 59
’21 10 14 42 (15) 51
’20 (10) 22 36 (3) 45
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.4
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 306 356 520 561 687 774 1,144 1,387 2,035 3,182 3,912 +29.7% 3,982 4,384 4,828 +14.9%
Gross margin, % 16.72 23.26 30.54 16.56 21.53 22.97 17.43 15.50 13.34 10.73 10.95 (6.0) pt
EBT 19 50 83 26 178 78 87 90 81 40 87 +8.6%
EBT margin, % 6.16 13.95 15.89 4.61 25.97 10.05 7.57 6.48 3.97 1.24 2.22 (4.9) pt
Net income 10 46 60 18 122 46 46 58 50 24 58 +10.2%
Per share, $
Per share, $ Revenue 12.40 13.96 15.81 16.15 18.81 17.66 25.44 29.79 42.75 64.83 79.46 +20.2%
Earnings 0.41 1.01 0.33 0.41 1.04 1.69 1.09 1.30 0.91 0.46 1.08 +1.4%
Cash flow 0.89 2.03 0.78 0.39 1.26 1.60 1.83 1.47 1.10 2.34 2.32 +11.3%
Capex (0.13) (0.08) (0.04) (0.03) (0.03) (0.44) (0.51) (0.61) (0.17) (0.21) (0.30) +4.9%
Free cash flow 0.75 1.95 0.74 0.36 1.23 1.17 1.32 0.85 0.93 2.13 2.02 +12.2%
Book value 3.55 6.43 5.52 5.54 9.06 10.36 12.10 13.25 15.06 16.16 17.64 +18.3%
Shares, m 25 26 33 35 37 44 45 47 48 49 49 +7.9%
Valuation, ×
Valuation, × P/E 0.00 13.37 60.15 46.03 17.40 43.74 25.93 29.38 35.03 53.93 35.97 32.5
P/S 0.00 1.59 1.26 1.14 0.97 4.16 1.11 1.30 0.74 0.38 0.49 1.3
P/B 0.00 3.73 3.60 3.32 2.02 7.09 2.33 2.93 2.09 1.53 2.20 2.9
EV/Sales 0.00 1.30 1.07 1.18 0.94 4.03 1.03 1.29 0.81 0.57 0.63 1.2
EV/FCF 0.00 10.03 22.96 52.35 14.38 61.02 19.98 45.05 37.29 17.48 24.69 28.1
Cash, $m
Cash, $m Operating cash flow 22 52 25 14 46 70 82 68 52 115 114 +20.2%
Capex (3) (2) (1) (1) (1) (19) (23) (29) (8) (10) (15) +13.2%
Free cash flow 19 50 24 13 45 51 59 40 44 104 99 +21.1%
Balance, $m
Balance, $m Working capital 31 35 101 224 224 290 280 243 273 248 194 +26.2%
Net debt (57) (113) (94) 22 (20) (102) (88) (17) 146 609 60 n/m
Shareholders’ equity 88 164 182 192 331 454 544 617 717 793 868 +27.7%
Returns, %
Returns, % ROA 6.20 10.09 2.16 2.27 4.87 8.18 4.93 6.39 3.77 1.26 2.32 (4.9) pt
ROIC 23.76 42.70 63.47 9.44 16.17 17.42 14.29 8.82 6.47 3.50 8.16 (20.3) pt
ROE 26.89 33.62 6.27 7.55 14.41 17.56 9.05 10.46 6.47 2.98 6.41 (23.9) pt
People
People Employees 150 493 492 555 630 1,133 1,362 1,800 1,900 3,000 — +39.5%
Revenue/emp, $m 0.00 0.72 1.06 1.01 1.09 0.68 0.84 0.77 1.07 1.06 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 6 Nov 2026

Astrana Health, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
MD Pediatrix Medical Group, Inc. $2.5B 17.1× 15.3× +1.72% (above 0%: growing) −27.61% (below 0%: shrinking) −14.41% (below 0%: shrinking) 27.98% 13.01% Compare
ADUS Addus HomeCare Corporation $2.4B 21.1× 20.3× +7.02% (above 0%: growing) +24.19% (above 0%: growing) −17.07% (below 0%: shrinking) 32.08% 10.27% Compare
ARDT Ardent Health, Inc. $2.2B 15.2× 12.8× +3.05% (above 0%: growing) n/m −23.49% (below 0%: shrinking) 100.00% 0.00% Compare
ASTH Astrana Health, Inc. $1.9B 46.8× 25.9× +48.52% (above 0%: growing) +110.53% (above 0%: growing) −67.74% (below 0%: shrinking) 10.70% 3.53%
AGL Agilon Health, Inc. $1.9B — (loss-making) — (loss-making) +5.86% (above 0%: growing) n/m +234.38% (above 0%: growing) 0.00% 1.59% Compare
AMN AMN Healthcare Services Inc $1.8B 17.4× 25.4× +2.29% (above 0%: growing) +117.88% (above 0%: growing) −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
HCSG Healthcare Services Group, Inc. $1.7B 16.6× 18.6× +3.29% (above 0%: growing) −37.29% (below 0%: shrinking) −59.81% (below 0%: shrinking) 16.76% 6.66% Compare
SNDA Sonida Senior Living, Inc. $1.6B — (loss-making) — (loss-making) +114.40% (above 0%: growing) n/m +360.11% (above 0%: growing) 35.68% (9.27%) Compare
PNTG The Pennant Group, Inc. $1.4B 37.3× 36.7× +31.96% (above 0%: growing) +55.56% (above 0%: growing) −3.19% (below 0%: shrinking) 13.34% 5.46% Compare
Median of peers $1.9B 17.2× 19.5× +4.58% +24.19% −15.74% 29.28% 4.73%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 17 April 2026

Ownership

Directors and executive officers, together 20.30%
BlackRock, Inc. 11.20%
Allied Physicians of California, A Professional Medical Corporation 11.00%
The Vanguard Group 7.60%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Astrana Health, Inc. (ASTH) Latest News

6 Nov

Impact 3 · · GuruFocus.com
Impact 3 · · The Motley Fool transcript

5 Nov

Impact 3 · · MarketBeat transcript
Impact 3 · · PR Newswire

19 Oct

Impact 4 · · GlobeNewswire
Impact 3 · · Simply Wall St.

16 Oct

Impact 3 · · StockStory

12 Oct

Impact 4 · · Simply Wall St.
Impact 3 · · Simply Wall St.
Impact 3 · · GlobeNewswire
Impact 3 · · Simply Wall St.

10 Oct

Impact 4 · · Business Wire

9 Oct

Impact 3 · · Simply Wall St.
Impact 3 · · PR Newswire
Impact 3 · · Zacks

8 Oct

Impact 3 · · StockStory

7 Oct

Impact 3 · · StockStory

23 Sep

Impact 4 · · StockStory

15 Aug

Impact 3 ·

13 Aug

Impact 3 · · The Motley Fool transcript

9 Aug

Impact 4 ·

7 Aug

Impact 4 ·

6 Aug

Impact 4 ·
Impact 3 ·
Impact 3 · · MarketBeat transcript
Impact 3 ·

13 Jul

Impact 4 ·

21 May

Impact 4 · · Simply Wall St.

17 May

Impact 3 · · StockStory

14 May

Impact 3 · · Insider Monkey
stockrow.com/ASTH · Data as of Nov 6, 2026 · For information only; not investment advice. · © 2026 stockrow.com